Wafa Asha

في عيد العمال… قررنا نطلع بمهمة بسيطة 💜 أن نرسم ابتسامة على وجوه موظفي مركز الحسين للسرطان 🌸 وأن نعبّر عن تقديرنا لعطائكم. لأنكم أنتم الأبطال وراء كل ابتسامة، والسبب في كل أمل يكبر يوما بعد يوم ✨ كل عام وأنتم أساس العطاء… وأنتم الأثر الحقيقي 💜 #عيد_العمال

Stage I Triple-Negative Breast Cancer: Moving From One-Size-Fits-All to a Personalized Approach @ASCO Educational Book👇 ascopubs.org/doi/full/10.12…

In healthcare, no amount of personal wellness practices can substitute for appropriate staffing, humane scheduling, efficient clinical workflows, adequate administrative support, or a culture of psychological safety.

🩻🦴SBRT vs conv EBRT → fracture risk? This comes up a lot at QA rounds. A recent review @JAMANetworkOpen was helpful: based on available RCTs, there appears to be no diff in fracture rates. SC.29 (led by @SahgalArjun @CDNCancerTrials) may add further insight.

As we increasingly adopt VMAT/IMRT for PMRT with RNI. What we contour defines DVH simple change in contouring SOP can have meaningful clinical implications ⁦@DocGlaser⁩ ⁦@ErinGillespieMD⁩ ⁦@bindhu2102⁩ ⁦⁦@AndrewKellerMD⁩ cancernetwork.com/view/a-multice…

📌 Optimizing Cardiac Dose Prediction in Left-Sided Breast Cancer Radiotherapy: Clinical Strategies for Identifying Beneficiaries of the Deep Inspiration Breath-Hold Technique 🔗 advancesradonc.org/article/S2452-… 👉🏻 This study highlights how advanced modeling can optimize patient selection for DIBH, improving cardiac sparing and personalizing treatment. 🫀 ☢️ The CNN-based model provides an efficient and accurate framework for predicting cardiac dose and identifying patients most likely to benefit from DIBH. #RadOnc #BreastCancer #DIBH @ASTRO_org

Thrilled to share our work: #radiotherapy management in BRCA1/2 carriers with early #breastcancer A big thank you to all collaborators - especially the outstanding team led by @matteolambe for this truly international effort Link: thegreenjournal.com/article/S0167-… @OncoAlert #OncoAlert

Today in @NatRevClinOncol : Multidisciplinary management of meningiomas in the era of precision oncology highlighting advances in molecular classifications, imaging, surgery, RT, and systemic therapies. @gelarehzadeh @sahm_lab @pkarschnia

"We are the books we read and the things we love." — Cath Crowley, Words in Deep Blue

One of the most widely shared videos worldwide. Brilliant lecture 🔥

📌 Advanced Triple-Negative Breast Cancer: Emerging Therapies and a Changing Treatment Landscape 🔗 ascopubs.org/doi/10.1200/ED… @OncoAlert #OncoAlertAF @HennessyMaeve @RitaNandaMD @hmcarthur 🧬 This review highlights current evidence and future challenges in advanced TNBC, including optimizing therapeutic sequencing and the ongoing need for predictive biomarkers and novel agents.

📌 Top 10 Tips for Stereotactic Body Radiation Therapy Contouring and Planning in Oligometastatic Disease: Lessons Learned From the UK SBRT QA Program ☢️ 🔗 sciencedirect.com/science/articl… @OncoAlert #OncoAlertAF @IJROBP @fifimcdrmh @royalmarsdenNHS 
🔹Standardize definitions.
🔸 Optimize use of supporting imaging. 🔹 Motion management. 🔸 Optimize patient preparation. 🔹 Use all available TPS tools to optimize contouring. 🔸 Check auto-contouring output. 🔹 Appropriate use of OAR dose-volume constraints. 🔸 Maximize PTV coverage. 🔹 Conform tightly to the PTV. 🔸 Managing multiple lesions.

“Whatever happens, happens. Stop obsessing over things you can’t control.”

قلوبنا ودعاؤنا مع أهلنا في لبنان. الحقُّ حقُّنا والأرضُ أرضُنا. #لبنان #بيروت #الجنوب

Beirut, Lebanon

Hey @mr_linac , treating near the esophagus? Check out this smart innovation from @UTSW_RadOnc Patients drink the "UTSW Pineapple Mix" to clearly visualize the esophagus on T2 SPIR. 🍍 Recipe: 1 packet Thick-It Original 2.5 oz 100% pineapple juice Thanks to Drs. Westover and Visak for sharing! #RadOnc #MedPhys @MHLinPhD @BobTimmermanMD @ArnoldPompos @GeinaIskander

World’s Best Smart Hospitals 2026

🤰 Cancer during pregnancy: ASCO Guideline at @JCO_ASCO! ascopubs.org/doi/10.1200/JC… 🎯 Multidisciplinary, patient-centered decision-making 📸 Imaging: follow ALARA principle ☝🏼 Systemic therapy → avoid 1st trimester; consider from 2nd 🛑 Contraindicated: MTX, anti-HER2, VEGF inhibitors, ADCs, cellular therapies Treating two patients, one decision ✨ @OncoAlert @OncoReporte @ASCO @myESMO @_SEOM @SuyogCancer